Education and Training
MD - Drexel University College of Medicine, Philadelphia, PA
Pediatrics - Children's National Medical Center, Washington, DC (Chief Resident)
Pediatric Pharmacoepidemiology Research - The Children's Hospital of Philadelphia, Philadelphia, PA
Pediatric Hematology/Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA
Neonatal Resuscitation Program (NRP)Pediatric Advanced Life Support (PALS)Pediatrics
MS in Clinical Epidemiology (MSCE) - University of Pennsylvania, Philadelphia, PA
Titles and Academic Titles
Assistant Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Departments and Services
DiNofia, A.M., Wang, X., Yannekis, G., Ogle, S., Hobbie, W.L., Carlson, C.A., Ginsberg, J.P. Analysis of semen parameters in a young cohort of cancer patients. Pediatric Blood and Cancer. 2016. Advance online publication. doi: 10.1002/pbc.26221.
DiNofia, A.M., Salazar, E., Seif, A.E., Li, Y., Huang, Y.S., Bagatell, R., Fisher, B.T., Aplenc, R. Bortezomib inpatient prescribing practices in free-standing children’s hospitals in the United States. PLoS One. 2016; 11(3):e0151362. doi: 10.1371/journal.pone.0151362.
Sadak, K., DiNofia, A., Reaman. G. Patient-perceived facilitators to the transition of survivorship care from the pediatric to the adult care-setting. Pediatric Blood and Cancer. 2013; 60(8):1365-8.
Posters and Presentations
K. Sadak, A. DiNofia, K. Shafer, K. Steacy. Parent perceptions on the transition of childhood cancer survivorship care from the pediatric to adult-care setting. Poster Presentation at the Long-Term Complications of Treatment of Children and Adolescents for Cancer, Arlington, VA, June 2015.
A. DiNofia, A. Seif, M. Devidas, et al. Resource utilization and cost analysis by treatment arm on the phase 3 high-risk B-precursor acute lymphoblastic leukemia trial AALL0232: a report from the Children's Oncology Group. Oral Presentation at 56th Annual American Society of Hematology Meeting and Exposition, December 2014.
Lectures by Invitation
A. DiNofia. The use of merged PHIS datasets in epidemiologic studies. Children's Hospital Association's Pediatric Analytics Conference. Kansas City, MO. September 2015.
A. DiNofia, A. Seif, M. Devidas, et al. Resource utilization and cost analysis by treatment arm on the phase 3 high-risk B precursor acute lymphoblastic leukemia trial AALL0232: a report from the Children’s Oncology Group. Oral Presentation at 56th Annual American Society of Hematology Meeting and Exposition, December 2014.
Awards and Honors
2016, Finalist, American Society of Hematology Research Training Fellow Award for Fellows
2014, Abstract Achievement Award, American Society of Hematology Meeting and Exposition
2014, Selected to represent fellowship class, The Children's Hospital of Philadelphia
2013, Excellence in Medical Student Education Award, Children’s National Medical Center
2012, The Doctor Maynard I. Cohen Memorial Award, Children’s National Medical Center
2012, Excellence in Medical Student Education Award, Children’s National Medical Center
2012, Coleman International Travel Grant, Children’s National Medical Center
2011, Excellence in Emergency Medicine, Children’s National Medical Center
2010, Excellence in Medical Student Education Award, Children’s National Medical Center
2004, Excellence in Medical Student Education Award, Children’s National Medical Center
2001, Leadership Scholar, Ursinus College
2000, Valedictorian, Archbishop Prendergast High School
Leadership and Memberships
Memberships in Professional Organizations
2016 – present, American Society of Pediatric Hematology/Oncology
2015 – present, American Society of Clinical Oncology
2014 – present, American Society of Hematology
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.